By Sahil Pandey and Christy Santhosh Oct 30 (Reuters) – The US Food and Drug Administration on Friday approved Inovio Pharmaceuticals’ treatment for a rare respiratory condition, marking the company’s first approved product. Shares of Inovio were up 257% in extended trading. Inovio’s therapy INO-310
Oct 30 (Reuters) – The death toll from the Ebola outbreak in Democratic Republic of Congo has surpassed 5,000, government data showed on Friday, as authorities had yet to find a way to control the country’s deadliest Ebola epidemic on record. There are no approved treatments or vaccines to combat th
Oct 30 (Reuters) – The US CDC on Friday reported 4,852 measles cases in the country as of October 29, up 264 cases from the previous update. Here are key details: • Nationwide, hospitalizations linked to measles this year stood at 511, representing 11% of all reported cases, according to the Centers
Oct 30 (Reuters) – The US health department on Friday approved the removal of the strictest “black box” warnings from the labels of three estradiol transdermal patches, the hormone therapies used to treat menopause symptoms. Women in the United States have been struggling to find hormone replacement
Oct 30 (Reuters) – The European Medicines Agency’s risk-monitoring committee said on Friday it had begun reviewing Deanxit, a depression and anxiety medicine by Danish drugmaker H Lundbeck, following reports of serious neurological and psychiatric side effects. The EMA’s Pharmacovigilance Risk Asses
By Kamal Choudhury and Christy Santhosh Oct 30 (Reuters) – AbbVie raised its annual profit forecast on Friday after topping Wall Street third-quarter expectations, driven by booming demand for its newer immunology and brain disease drugs, sending its shares up 1%. The drugmaker’s shares have risen a
By Nancy Lapid Oct 30 (Reuters) – Today we report on a troubling cancer trend among US adults of all ages. We also report on impressive survival data from a two-drug regimen that could be an alternative to more expensive immunotherapies for some patients with a type of advanced kidney cancer. COLORE
By Rishika Sadam HYDERABAD, Oct 30 (Reuters) – Omron Healthcare, the medical-device unit of Japan’s Omron Corp, opened its first Indian factory on Friday as part of its plans to reduce its reliance on Vietnam and target a largely untapped domestic market for blood pressure monitors. India could even
PARIS, Oct 30 (Reuters) – France is recalling more condoms after its consumer watchdog said on Friday it had found they had manufacturing defects that raised the risk of them bursting and ripping. The agency said it was suspending for a year sales and imports of all condom brands that were made by a
Oct 30 (Reuters) – India’s Max Healthcare Institute reported a 15.6% fall in second-quarter profit on Friday, as the absence of a one-time tax benefit from a year earlier overshadowed growth in patient volumes across its expanding hospital network. The hospital operator’s consolidated net profit fel
By Rishika Sadam HYDERABAD, Oct 30 (Reuters) – Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failure in its quality management system, documents reviewed by Reuters showed. The
Oct 30 (Reuters) – India’s Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as a one-time charge largely tied to its planned acquisition of Organon weighed, though demand for specialty medicines remained strong. The country’s top drugmaker by revenue posted a consoli
By Pushkala Aripaka and Patrick Wingrove Oct 30 (Reuters) – AstraZeneca unveiled plans on Friday to save about $1.5 billion annually to invest in its drug pipeline, sparking the biggest one-day share rally in a year as CEO Pascal Soriot moved to shift the focus back to growth after a turbulent few m
By Bhanvi Satija LONDON, Oct 30 (Reuters) – French drugmaker Sanofi said on Friday it was prepared to pursue larger deals as it seeks to rebuild its basket of experimental drugs for future growth under new CEO Belen Garijo. Shares in the company rose more than 5% and were among the top gainers in Eu
NEW YORK, Oct 29 (Reuters) – Bayer won a US court trial on Thursday over claims by three women that Roundup had caused their cancer cases. (Reporting by Dietrich Knauth; Editing by Muralikumar Anantharaman) Brought to you by www.srnnews.com
By Deena Beasley Oct 29 (Reuters) – Gilead Sciences hiked its full-year sales outlook on Thursday and reported third-quarter product sales rose 13%, driven by a double-digit percentage jump for its flagship HIV drug franchise. The company reported quarterly adjusted earnings of $2.55 per share on re
Oct 29 (Reuters) – The World Health Organization said on Thursday that member states have proposed seven candidates for the position of WHO director-general, with the successful candidate expected to take office on August 16, 2027. The World Health Assembly will appoint the new director-general at i
Oct 29 (Reuters) – The US Food and Drug Administration proposed new nutrient limits and labeling rules for infant formula on Thursday, as part of its ongoing review of baby formula nutrients. The FDA launched “Operation Stork Speed” last year, which began a nutrient review process and increased test
Oct 29 (Reuters) – The US Food and Drug Administration on Thursday warned of safety risks associated with Medline beds and accessories after the company reported two deaths and 16 serious injuries linked to fire, entrapment and asphyxiation hazards. According to the regulator, Medline has told custo
Oct 29 (Reuters) – Perrigo said on Thursday that it will sell its infant formula business to privately held contract manufacturing firm MeridianMade for up to $175 million, as the consumer health products company sharpens its focus on over-the-counter medicines and self-care products. Here are some
By Deena Beasley and Sneha S K Oct 29 (Reuters) – Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to a hefty acquisition-related charge. The US drugmaker now expects 2026 adjus
By Michael Erman and Kamal Choudhury NEW YORK, Oct 29 (Reuters) – Merck said on Thursday it plans to raise its revenue forecast from new products over the next decade, buoyed by recent clinical trial successes and acquisitions, as the company prepares for the loss of patent protection on blockbuster
By Richa Naidu LONDON, Oct 29 (Reuters) – Haleon CEO Brian McNamara warned staff on Thursday that the British maker of Sensodyne toothpaste and Beechams cold medicines faced “difficult choices” in coming months, according to a memo seen by Reuters, after the group cut its annual revenue growth outlo
ZURICH, Oct 29 (Reuters) – Switzerland’s Molecular Partners is cutting its workforce nearly in half, it said on Thursday, as it aims to narrow its focus on the booming field of radiotherapeutic medicines. The clinical-stage biotech company, which has partnered with pharma giant Novartis and American
By Raechel Thankam Job Oct 29 (Reuters) – Haleon cut its sales outlook to below market forecasts on Thursday, hurt by weak demand for flu and cold medicines and a regulatory setback in China, sparking the biggest-ever one-day fall in the British consumer health group’s shares. The stock, spun off fr
By Yantoultra Ngui HONG KONG, Oct 29 (Reuters) – Malaysian hospital operator Asia OneHealthcare has filed a draft prospectus for an initial public offering of up to 4.38 billion shares and a planned listing on Bursa Malaysia, the Securities Commission Malaysia’s website showed on Wednesday. • Reuter
By Yantoultra Ngui HONG KONG, Oct 29 (Reuters) – Malaysian pharmacy chain Big Caring Group on Thursday launches its initial public offering, which could value the company at about 8 billion ringgit ($2 billion) ahead of a planned November 19 listing debut on Bursa Malaysia. The retailer is offering
By Dietrich Knauth Oct 28 (Reuters) – A US bankruptcy judge on Wednesday ruled that Richard Sackler and his wife Lin Gao must stop interfering with efforts to sell their Connecticut mansion to help pay for Purdue Pharma’s $7.4 billion bankruptcy settlement with opioid claimants. US Bankruptcy Judge
By Tom Polansek WASHINGTON, Oct 28 (Reuters) – New World screwworm, a parasitic fly that eats warm-blooded animals alive, has infested a dog in Arizona, widening cases to a third US state, the US Department of Agriculture said on Wednesday. The first detection in Arizona was in Cochise County, which
Oct 28 (Reuters) – Oura said on Wednesday it has launched a clinical trial to study how sleep, heart rate and other measures monitored by the company’s smart ring are associated with outcomes of obesity treatments such as GLP-1 drugs and bariatric surgery. The trial will examine whether changes in t
